Live news related to INVENTIVA stock (FR0013233012): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Inventiva, a biopharmaceutical company, will present four abstracts related to digital pathology at the upcoming American Association for the Study of…
The French biotech recorded a 5.82% increase this Tuesday, closing at €4.00, while the CAC 40 slightly declined by 0.18%.
The French biotech specializing in the treatment of MASH closed sharply lower on Monday, extending a significant weekly correction.
The share price of the biopharmaceutical company specializing in the development of oral therapies for the treatment of MASH closed at €3.9850, signif…
